PARMAR KUSH
SEC insider (Form 3/4/5 filer). CIK 0001664281. Director & 10% Owner at Entrada Therapeutics, Inc. (TRDA). 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN FRANCISCO, CA.
Companies PARMAR KUSH has filed insider reports for
- Entrada Therapeutics, Inc. (TRDA): Director, 10% Owner
PARMAR KUSH
CIK: 0001664281
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Entrada Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 10, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect92.4K shares at avg. $7.00$647K - Aug 7, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect52.3K shares at avg. $6.85$358K - Aug 6, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect10.5K shares at avg. $7.00$73K - Jul 31, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect1.7K shares at avg. $6.85$12K - Jul 30, 2026TRDA
Entrada Therapeutics, Inc.
SaleIndirect114.8K shares at avg. $6.93$795K - Jun 10, 2026TRDA
Entrada Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19K shares- - Nov 14, 2025TRDA
Entrada Therapeutics, Inc.
SaleIndirect200K shares at avg. $8.80$1.8M - Jul 9, 2025TRDA
Entrada Therapeutics, Inc.
SaleIndirect6.9K shares at avg. $7.50$52K - Jul 9, 2025TRDA
Entrada Therapeutics, Inc.
SaleIndirect20.1K shares at avg. $7.50$151K - Jul 1, 2025TRDA
Entrada Therapeutics, Inc.
SaleIndirect18.6K shares at avg. $7.12$132K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 92,444 | $7.00 | $647,108 | Indirect |
| Aug 7, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 52,317 | $6.85 | $358,371 | Indirect |
| Aug 6, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 10,494 | $7.00 | $73,458 | Indirect |
| Jul 31, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 1,718 | $6.85 | $11,768 | Indirect |
| Jul 30, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 114,756 | $6.93 | $795,259 | Indirect |
| Jun 10, 2026 | TRDA Entrada Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| Nov 14, 2025 | TRDA Entrada Therapeutics, Inc. | Sale | 200,000 | $8.80 | $1,760,000 | Indirect |
| Jul 9, 2025 | TRDA Entrada Therapeutics, Inc. | Sale | 6,935 | $7.50 | $52,026 | Indirect |
| Jul 9, 2025 | TRDA Entrada Therapeutics, Inc. | Sale | 20,065 | $7.50 | $150,528 | Indirect |
| Jul 1, 2025 | TRDA Entrada Therapeutics, Inc. | Sale | 18,578 | $7.12 | $132,324 | Indirect |
1-10 of 16 transactions